IBDEI053 ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6538,1,3,0)
 ;;=3^Toxic Maculopathy
 ;;^UTILITY(U,$J,358.3,6538,1,4,0)
 ;;=4^362.55
 ;;^UTILITY(U,$J,358.3,6538,2)
 ;;=Toxic Maculopathy^268640
 ;;^UTILITY(U,$J,358.3,6539,0)
 ;;=363.31^^51^452^99
 ;;^UTILITY(U,$J,358.3,6539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6539,1,3,0)
 ;;=3^Solar Retinopathy
 ;;^UTILITY(U,$J,358.3,6539,1,4,0)
 ;;=4^363.31
 ;;^UTILITY(U,$J,358.3,6539,2)
 ;;=Solar Retinopathy^265207
 ;;^UTILITY(U,$J,358.3,6540,0)
 ;;=363.32^^51^452^56
 ;;^UTILITY(U,$J,358.3,6540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6540,1,3,0)
 ;;=3^Macular Scars
 ;;^UTILITY(U,$J,358.3,6540,1,4,0)
 ;;=4^363.32
 ;;^UTILITY(U,$J,358.3,6540,2)
 ;;=Macular Scars^268680
 ;;^UTILITY(U,$J,358.3,6541,0)
 ;;=362.83^^51^452^53
 ;;^UTILITY(U,$J,358.3,6541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6541,1,3,0)
 ;;=3^Macular Edema (Csme)
 ;;^UTILITY(U,$J,358.3,6541,1,4,0)
 ;;=4^362.83
 ;;^UTILITY(U,$J,358.3,6541,2)
 ;;=Macular Edema (CSME)^89576
 ;;^UTILITY(U,$J,358.3,6542,0)
 ;;=362.84^^51^452^87
 ;;^UTILITY(U,$J,358.3,6542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6542,1,3,0)
 ;;=3^Retinal Ischemia
 ;;^UTILITY(U,$J,358.3,6542,1,4,0)
 ;;=4^362.84
 ;;^UTILITY(U,$J,358.3,6542,2)
 ;;=Retinal Ischemia^276868
 ;;^UTILITY(U,$J,358.3,6543,0)
 ;;=363.20^^51^452^14
 ;;^UTILITY(U,$J,358.3,6543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6543,1,3,0)
 ;;=3^Chorioretinitis
 ;;^UTILITY(U,$J,358.3,6543,1,4,0)
 ;;=4^363.20
 ;;^UTILITY(U,$J,358.3,6543,2)
 ;;=Chorioretinitis^23913
 ;;^UTILITY(U,$J,358.3,6544,0)
 ;;=115.92^^51^452^43
 ;;^UTILITY(U,$J,358.3,6544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6544,1,3,0)
 ;;=3^Histoplamosis (Pohs)
 ;;^UTILITY(U,$J,358.3,6544,1,4,0)
 ;;=4^115.92
 ;;^UTILITY(U,$J,358.3,6544,2)
 ;;=Histoplamosis Retinitis^266905
 ;;^UTILITY(U,$J,358.3,6545,0)
 ;;=363.70^^51^452^15
 ;;^UTILITY(U,$J,358.3,6545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6545,1,3,0)
 ;;=3^Choroidal Detachment
 ;;^UTILITY(U,$J,358.3,6545,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,6545,2)
 ;;=Choroidal Detachment^276841
 ;;^UTILITY(U,$J,358.3,6546,0)
 ;;=363.63^^51^452^19
 ;;^UTILITY(U,$J,358.3,6546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6546,1,3,0)
 ;;=3^Choroidal Rupture
 ;;^UTILITY(U,$J,358.3,6546,1,4,0)
 ;;=4^363.63
 ;;^UTILITY(U,$J,358.3,6546,2)
 ;;=Choroidal Rupture^268698
 ;;^UTILITY(U,$J,358.3,6547,0)
 ;;=379.22^^51^452^5
 ;;^UTILITY(U,$J,358.3,6547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6547,1,3,0)
 ;;=3^Asteroid Hyalosis
 ;;^UTILITY(U,$J,358.3,6547,1,4,0)
 ;;=4^379.22
 ;;^UTILITY(U,$J,358.3,6547,2)
 ;;=Asteroid Hyalosis^269310
 ;;^UTILITY(U,$J,358.3,6548,0)
 ;;=379.21^^51^452^104
 ;;^UTILITY(U,$J,358.3,6548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6548,1,3,0)
 ;;=3^Vitreous Detachment/Degeneration (Pvd)
 ;;^UTILITY(U,$J,358.3,6548,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,6548,2)
 ;;=Vitreous Detachment/Degeneration^88242
 ;;^UTILITY(U,$J,358.3,6549,0)
 ;;=379.24^^51^452^105
 ;;^UTILITY(U,$J,358.3,6549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6549,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,6549,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,6549,2)
 ;;=Vitreous Floaters^88242
 ;;^UTILITY(U,$J,358.3,6550,0)
 ;;=379.26^^51^452^107
 ;;^UTILITY(U,$J,358.3,6550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6550,1,3,0)
 ;;=3^Vitreous Prolapse
 ;;^UTILITY(U,$J,358.3,6550,1,4,0)
 ;;=4^379.26
 ;;^UTILITY(U,$J,358.3,6550,2)
 ;;=Vitreous Prolapse^269312
 ;;^UTILITY(U,$J,358.3,6551,0)
 ;;=379.23^^51^452^106
 ;;^UTILITY(U,$J,358.3,6551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6551,1,3,0)
 ;;=3^Vitreous Hemorrhage
 ;;^UTILITY(U,$J,358.3,6551,1,4,0)
 ;;=4^379.23
 ;;^UTILITY(U,$J,358.3,6551,2)
 ;;=Vitreous Hemorrhage^127096
 ;;^UTILITY(U,$J,358.3,6552,0)
 ;;=362.18^^51^452^89
 ;;^UTILITY(U,$J,358.3,6552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6552,1,3,0)
 ;;=3^Retinal Vasculitis
 ;;^UTILITY(U,$J,358.3,6552,1,4,0)
 ;;=4^362.18
 ;;^UTILITY(U,$J,358.3,6552,2)
 ;;=Retinal Vasculitis^264463
 ;;^UTILITY(U,$J,358.3,6553,0)
 ;;=360.21^^51^452^31
 ;;^UTILITY(U,$J,358.3,6553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6553,1,3,0)
 ;;=3^Degenerative Myopia
 ;;^UTILITY(U,$J,358.3,6553,1,4,0)
 ;;=4^360.21
 ;;^UTILITY(U,$J,358.3,6553,2)
 ;;=Degenerative Myopia^268553
 ;;^UTILITY(U,$J,358.3,6554,0)
 ;;=362.64^^51^452^80
 ;;^UTILITY(U,$J,358.3,6554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6554,1,3,0)
 ;;=3^Reticular Degeneration
 ;;^UTILITY(U,$J,358.3,6554,1,4,0)
 ;;=4^362.64
 ;;^UTILITY(U,$J,358.3,6554,2)
 ;;=Reticular Degeneration^268645
 ;;^UTILITY(U,$J,358.3,6555,0)
 ;;=362.61^^51^452^29
 ;;^UTILITY(U,$J,358.3,6555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6555,1,3,0)
 ;;=3^Degeneration, Paving Stone
 ;;^UTILITY(U,$J,358.3,6555,1,4,0)
 ;;=4^362.61
 ;;^UTILITY(U,$J,358.3,6555,2)
 ;;=Paving Stone Degeneration^268642
 ;;^UTILITY(U,$J,358.3,6556,0)
 ;;=362.42^^51^452^94
 ;;^UTILITY(U,$J,358.3,6556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6556,1,3,0)
 ;;=3^Rpe Detachment, Serous
 ;;^UTILITY(U,$J,358.3,6556,1,4,0)
 ;;=4^362.42
 ;;^UTILITY(U,$J,358.3,6556,2)
 ;;=Serous RPE Detachment^268633
 ;;^UTILITY(U,$J,358.3,6557,0)
 ;;=362.43^^51^452^93
 ;;^UTILITY(U,$J,358.3,6557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6557,1,3,0)
 ;;=3^Rpe Detachment, Hemorrhagic
 ;;^UTILITY(U,$J,358.3,6557,1,4,0)
 ;;=4^362.43
 ;;^UTILITY(U,$J,358.3,6557,2)
 ;;=Hemorrhagic RPE Detachment^268634
 ;;^UTILITY(U,$J,358.3,6558,0)
 ;;=250.00^^51^452^34
 ;;^UTILITY(U,$J,358.3,6558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6558,1,3,0)
 ;;=3^Dm Type II, No Retinopathy
 ;;^UTILITY(U,$J,358.3,6558,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6558,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,6559,0)
 ;;=250.01^^51^452^33
 ;;^UTILITY(U,$J,358.3,6559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6559,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,6559,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,6559,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,6560,0)
 ;;=250.50^^51^452^25
 ;;^UTILITY(U,$J,358.3,6560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6560,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,6560,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6560,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,6561,0)
 ;;=250.51^^51^452^27
 ;;^UTILITY(U,$J,358.3,6561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6561,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,6561,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,6561,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,6562,0)
 ;;=362.01^^51^452^32
 ;;^UTILITY(U,$J,358.3,6562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6562,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,6562,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,6562,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,6563,0)
 ;;=362.02^^51^452^72
 ;;^UTILITY(U,$J,358.3,6563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6563,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,6563,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,6563,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,6564,0)
 ;;=362.03^^51^452^64
 ;;^UTILITY(U,$J,358.3,6564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6564,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,6564,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,6564,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,6565,0)
 ;;=362.04^^51^452^61
 ;;^UTILITY(U,$J,358.3,6565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6565,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,6565,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,6565,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,6566,0)
 ;;=362.05^^51^452^62
 ;;^UTILITY(U,$J,358.3,6566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6566,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,6566,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,6566,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,6567,0)
 ;;=362.06^^51^452^98
 ;;^UTILITY(U,$J,358.3,6567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6567,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,6567,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,6567,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,6568,0)
 ;;=379.27^^51^452^103
 ;;^UTILITY(U,$J,358.3,6568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6568,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,6568,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,6568,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,6569,0)
 ;;=115.02^^51^452^44
 ;;^UTILITY(U,$J,358.3,6569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6569,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,6569,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,6569,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,6570,0)
 ;;=190.5^^51^452^58
 ;;^UTILITY(U,$J,358.3,6570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6570,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,6570,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,6570,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,6571,0)
 ;;=198.4^^51^452^59
 ;;^UTILITY(U,$J,358.3,6571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6571,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,6571,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,6571,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,6572,0)
 ;;=200.00^^51^452^81
 ;;^UTILITY(U,$J,358.3,6572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6572,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,6572,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,6572,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,6573,0)
 ;;=228.03^^51^452^38
 ;;^UTILITY(U,$J,358.3,6573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6573,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,6573,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,6573,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,6574,0)
 ;;=228.09^^51^452^39
 ;;^UTILITY(U,$J,358.3,6574,1,0)
 ;;=^358.31IA^4^2
